Our top pick for
XPEL Inc is an auto parts business based in the US. XPEL shares (XPEL) are listed on the NASDAQ and all prices are listed in US Dollars. XPEL employs 330 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$77.03|
|52-week range||$24.60 - $103.84|
|50-day moving average||$77.72|
|200-day moving average||$77.68|
|Wall St. target price||$110.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.08|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||8.29%|
|1 month (2021-09-22)||-7.29%|
|3 months (2021-07-22)||-21.92%|
|6 months (2021-04-22)||22.52%|
|1 year (2020-10-22)||189.59%|
|2 years (2019-10-22)||647.86%|
|3 years (2018-10-22)||1,122.99%|
|5 years (2016-10-19)||5,825.38%|
Valuing XPEL stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of XPEL's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
XPEL's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 66x. In other words, XPEL shares trade at around 66x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
XPEL's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $39.7 million.
The EBITDA is a measure of a XPEL's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$215.3 million|
|Operating margin TTM||17.17%|
|Gross profit TTM||$54 million|
|Return on assets TTM||26.63%|
|Return on equity TTM||54.14%|
|Market capitalisation||$2 billion|
TTM: trailing 12 months
There are currently 1.1 million XPEL shares held short by investors – that's known as XPEL's "short interest". This figure is 4.6% down from 1.1 million last month.
There are a few different ways that this level of interest in shorting XPEL shares can be evaluated.
XPEL's "short interest ratio" (SIR) is the quantity of XPEL shares currently shorted divided by the average quantity of XPEL shares traded daily (recently around 258075.30266344). XPEL's SIR currently stands at 4.13. In other words for every 100,000 XPEL shares traded daily on the market, roughly 4130 shares are currently held short.
However XPEL's short interest can also be evaluated against the total number of XPEL shares, or, against the total number of tradable XPEL shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case XPEL's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 XPEL shares in existence, roughly 40 shares are currently held short) or 0.0588% of the tradable shares (for every 100,000 tradable XPEL shares, roughly 59 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against XPEL.
Find out more about how you can short XPEL stock.
We're not expecting XPEL to pay a dividend over the next 12 months.
Over the last 12 months, XPEL's shares have ranged in value from as little as $24.6 up to $103.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XPEL's is 1.5947. This would suggest that XPEL's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
XPEL, Inc. manufactures, sells, distributes, and installs after-market automotive products in the United States, China, Canada, Continental Europe, the United Kingdom, Asia Pacific, Latin America, the Middle East/Africa, and internationally. The company offers automotive surface and paint protection, headlight protection, and automotive and architectural window films, as well as proprietary software. It also provides merchandise and apparel, and ceramic coatings. In addition, the company offers paint protection kits, car wash products, after-care products, and installation tools through its website. It sells its products to independent installers and new car dealerships, third party distributors, owned installation centers, and franchisees and online. The company was founded in 1997 and is headquartered in San Antonio, Texas.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.